Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma
暂无分享,去创建一个
Urvashi Surti | U. Surti | S. Gollin | U. Rao | Susanne M Gollin | Uma N M Rao | Kathleen Cieply | Carol Sherer | K. Cieply | C. Sherer
[1] P. Picci,et al. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma. , 2014, The Journal of molecular diagnostics : JMD.
[2] Jean McGowan-Jordan,et al. ISCN 2013 : an international system for human cytogenetic nomenclature (2013) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature , 2005 .
[3] Zhong Jiang,et al. Overlapping Features Between Dedifferentiated Liposarcoma and Undifferentiated High-Grade Pleomorphic Sarcoma , 2009, The American journal of surgical pathology.
[4] P. D. Dal Cin,et al. The application of cytogenetics and fluorescence in situ hybridization to fine‐needle aspiration in the diagnosis and subclassification of renal neoplasms , 2010, Cancer cytopathology.
[5] N. Mandahl. Cytogenetics and molecular genetics of bone and soft tissue tumors. , 1996, Advances in cancer research.
[6] M. Ladanyi,et al. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. , 2000, The Journal of molecular diagnostics : JMD.
[7] J. Goldblum,et al. The Utility of Fluorescence In Situ Hybridization (FISH) in the Diagnosis of Myxoid Soft Tissue Neoplasms , 2008, The American journal of surgical pathology.
[8] A. Nicholson,et al. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma , 2007, Modern Pathology.
[9] G. Bar-Sela,et al. Expression of heparanase in soft tissue sarcomas of adults , 2014, Journal of experimental & clinical cancer research : CR.
[10] B. Tops,et al. NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma , 2012, Virchows Archiv.
[11] P. Terrier,et al. Detection of MDM2-CDK4 Amplification by Fluorescence In Situ Hybridization in 200 Paraffin-embedded Tumor Samples: Utility in Diagnosing Adipocytic Lesions and Comparison With Immunohistochemistry and Real-time PCR , 2007, The American journal of surgical pathology.
[12] C. Fisher. Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations , 2010, Virchows Archiv.
[13] A. Sandberg. Cytogenetics and molecular genetics of bone and soft-tissue tumors. , 2002, American journal of medical genetics.
[14] D. Jong,et al. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis , 2009, Modern Pathology.
[15] N. Mandahl,et al. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma , 1995, International journal of cancer.
[16] F. Collin,et al. Translocation-positive Low-grade Fibromyxoid Sarcoma: Clinicopathologic and Molecular Analysis of a Series Expanding the Morphologic Spectrum and Suggesting Potential Relationship to Sclerosing Epithelioid Fibrosarcoma: A Study From the French Sarcoma Group , 2007, The American journal of surgical pathology.
[17] O. Larsson,et al. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma , 2014, Oncogene.
[18] A. Lazar,et al. New Therapeutic Targets in Soft Tissue Sarcoma , 2012, Advances in anatomic pathology.
[19] M. Smith. Molecular Testing for Lipomatous Tumors: Critical Analysis and Test Recommendations Based on the Analysis of 405 Extremity-based Tumors , 2011 .
[20] B. Johansson,et al. The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.
[21] P. Åman,et al. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. , 2003, The American journal of pathology.
[22] E. Mayordomo,et al. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts) , 2009, Modern Pathology.
[23] R. Sciot,et al. Complex tumor-specific t(X;18) in seven synovial sarcoma tumors. , 2009, Cancer genetics and cytogenetics.
[24] B. Nilsson,et al. Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line. , 2008, Cancer letters.
[25] J. Fletcher,et al. HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status , 2014, Oncotarget.
[26] U. Surti,et al. Malignant granular cell tumor of the ulnar nerve with novel cytogenetic and molecular genetic findings. , 2009, Cancer genetics and cytogenetics.
[27] Yu-ping Wang,et al. Characterization of Human Chromosomal Material Exchange with Regard to the Chromosome Translocations Using Next-Generation Sequencing Data , 2014, Genome biology and evolution.
[28] A. Sandberg,et al. Chromosomes in the diagnosis of soft tissue tumors. I. Synovial sarcoma. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[29] J. Quesada,et al. The Molecular Biology of Soft-Tissue Sarcomas and Current Trends in Therapy , 2012, Sarcoma.
[30] Nicolò Riggi,et al. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. , 2006, Cancer research.
[31] L. Chan,et al. Pathogenesis of jumping translocations: a molecular cytogenetics study. , 2004, Leukemia research.
[32] Dafydd G. Thomas,et al. Cutaneous and Subcutaneous Pleomorphic Liposarcoma: A Clinicopathologic Study of 29 Cases With Evaluation of MDM2 Gene Amplification in 26 , 2012, The American journal of surgical pathology.
[33] Olivier Delattre,et al. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] P. D. Dal Cin,et al. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. , 2002, Cancer Research.
[35] P. D. Dal Cin,et al. Well‐differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases , 2013, Histopathology.
[36] Wei-min Li,et al. Mechanisms Underlying Regulation of Cell Cycle and Apoptosis by hnRNP B1 in Human Lung Adenocarcinoma A549 Cells , 2014, Tumori.
[37] C. Fisher,et al. Tumors With EWSR1-CREB1 and EWSR1-ATF1 Fusions: The Current Status , 2012, The American journal of surgical pathology.
[38] J. Bridge. The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors , 2014, Modern Pathology.
[39] F. Mertens,et al. HMGA2 and MDM2 expression in lipomatous tumors with partial, low-level amplification of sequences from the long arm of chromosome 12. , 2011, Cancer genetics.
[40] C. Corless. Gastrointestinal stromal tumors: what do we know now? , 2014, Modern Pathology.